279 related articles for article (PubMed ID: 21285158)
1. An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Davì S; Consolaro A; Guseinova D; Pistorio A; Ruperto N; Martini A; Cron RQ; Ravelli A;
J Rheumatol; 2011 Apr; 38(4):764-8. PubMed ID: 21285158
[TBL] [Abstract][Full Text] [Related]
2. [Macrophage activation syndrome and systemic onset of juvenile idiopathic arthritis].
Iglesias Jiménez E; Camacho Lovillo MS; Lirola Cruz MJ; Falcón Neyra D; Neth O
An Pediatr (Barc); 2010 Mar; 72(3):230-1. PubMed ID: 20097627
[No Abstract] [Full Text] [Related]
3. Recurrent macrophage activation syndrome associated with heterozygous perforin W374X gene mutation in a child with systemic juvenile idiopathic arthritis.
Unal S; Balta G; Okur H; Aytac S; Cetin M; Gumruk F; Ozen S; Gurgey A
J Pediatr Hematol Oncol; 2013 Jul; 35(5):e205-8. PubMed ID: 23274377
[TBL] [Abstract][Full Text] [Related]
4. Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis.
Shimizu M; Yokoyama T; Yamada K; Kaneda H; Wada H; Wada T; Toma T; Ohta K; Kasahara Y; Yachie A
Rheumatology (Oxford); 2010 Sep; 49(9):1645-53. PubMed ID: 20472718
[TBL] [Abstract][Full Text] [Related]
5. Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis.
Yanagimachi M; Naruto T; Miyamae T; Hara T; Kikuchi M; Hara R; Imagawa T; Mori M; Sato H; Goto H; Yokota S
J Rheumatol; 2011 Apr; 38(4):769-74. PubMed ID: 21239750
[TBL] [Abstract][Full Text] [Related]
6. Defining criteria for macrophage activation syndrome, a process towards early recognition and treatment.
Wulffraat NM
J Rheumatol; 2011 Apr; 38(4):593-4. PubMed ID: 21459955
[No Abstract] [Full Text] [Related]
7. Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis.
Lehmberg K; Pink I; Eulenburg C; Beutel K; Maul-Pavicic A; Janka G
J Pediatr; 2013 Jun; 162(6):1245-51. PubMed ID: 23333131
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis.
Vastert SJ; van Wijk R; D'Urbano LE; de Vooght KM; de Jager W; Ravelli A; Magni-Manzoni S; Insalaco A; Cortis E; van Solinge WW; Prakken BJ; Wulffraat NM; de Benedetti F; Kuis W
Rheumatology (Oxford); 2010 Mar; 49(3):441-9. PubMed ID: 20019066
[TBL] [Abstract][Full Text] [Related]
9. Recognition and management of macrophage activation syndrome in juvenile arthritis.
Kelly A; Ramanan AV
Curr Opin Rheumatol; 2007 Sep; 19(5):477-81. PubMed ID: 17762614
[TBL] [Abstract][Full Text] [Related]
10. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis.
Behrens EM; Beukelman T; Paessler M; Cron RQ
J Rheumatol; 2007 May; 34(5):1133-8. PubMed ID: 17343315
[TBL] [Abstract][Full Text] [Related]
11. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Ravelli A; Magni-Manzoni S; Pistorio A; Besana C; Foti T; Ruperto N; Viola S; Martini A
J Pediatr; 2005 May; 146(5):598-604. PubMed ID: 15870661
[TBL] [Abstract][Full Text] [Related]
12. Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids.
Bruck N; Suttorp M; Kabus M; Heubner G; Gahr M; Pessler F
J Clin Rheumatol; 2011 Jan; 17(1):23-7. PubMed ID: 21169853
[TBL] [Abstract][Full Text] [Related]
13. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.
Parodi A; Davì S; Pringe AB; Pistorio A; Ruperto N; Magni-Manzoni S; Miettunen P; Bader-Meunier B; Espada G; Sterba G; Ozen S; Wright D; Magalhães CS; Khubchandani R; Michels H; Woo P; Iglesias A; Guseinova D; Bracaglia C; Hayward K; Wouters C; Grom A; Vivarelli M; Fischer A; Breda L; Martini A; Ravelli A;
Arthritis Rheum; 2009 Nov; 60(11):3388-99. PubMed ID: 19877067
[TBL] [Abstract][Full Text] [Related]
14. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Ravelli A; Minoia F; Davì S; Horne A; Bovis F; Pistorio A; Aricò M; Avcin T; Behrens EM; De Benedetti F; Filipovic L; Grom AA; Henter JI; Ilowite NT; Jordan MB; Khubchandani R; Kitoh T; Lehmberg K; Lovell DJ; Miettunen P; Nichols KE; Ozen S; Pachlopnik Schmid J; Ramanan AV; Russo R; Schneider R; Sterba G; Uziel Y; Wallace C; Wouters C; Wulffraat N; Demirkaya E; Brunner HI; Martini A; Ruperto N; Cron RQ; ; ; ;
Arthritis Rheumatol; 2016 Mar; 68(3):566-76. PubMed ID: 26314788
[TBL] [Abstract][Full Text] [Related]
15. A case of macrophage activation syndrome successfully treated with anakinra.
Kelly A; Ramanan AV
Nat Clin Pract Rheumatol; 2008 Nov; 4(11):615-20. PubMed ID: 18825135
[TBL] [Abstract][Full Text] [Related]
16. Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities.
Naveen R; Jain A; Muhammed H; Gupta L; Misra DP; Lawrence A; Agarwal V; Misra R; Aggarwal A
Rheumatol Int; 2021 Mar; 41(3):625-631. PubMed ID: 33388903
[TBL] [Abstract][Full Text] [Related]
17. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Ravelli A; Minoia F; Davì S; Horne A; Bovis F; Pistorio A; Aricò M; Avcin T; Behrens EM; De Benedetti F; Filipovic L; Grom AA; Henter JI; Ilowite NT; Jordan MB; Khubchandani R; Kitoh T; Lehmberg K; Lovell DJ; Miettunen P; Nichols KE; Ozen S; Pachlopnik Schmid J; Ramanan AV; Russo R; Schneider R; Sterba G; Uziel Y; Wallace C; Wouters C; Wulffraat N; Demirkaya E; Brunner HI; Martini A; Ruperto N; Cron RQ; ; ; ;
Ann Rheum Dis; 2016 Mar; 75(3):481-9. PubMed ID: 26865703
[TBL] [Abstract][Full Text] [Related]
18. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Likhacheva TS; Isupova EA; Glebova NI; Kuchinskaya EM; Balbotkina EV; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
Semin Arthritis Rheum; 2015 Feb; 44(4):417-22. PubMed ID: 25300700
[TBL] [Abstract][Full Text] [Related]
19. [Multi-organ failure as first clinical sign of macrophage activation syndrome in childhood Still's disease].
López-Sánchez M; Rubio-López I; Obeso-González T; Teja-Barbero JL; Santidrián-Miguel JP; Peiro-Callizo E
An Pediatr (Barc); 2010 Oct; 73(4):194-8. PubMed ID: 20643591
[TBL] [Abstract][Full Text] [Related]
20. The incidence of macrophage activation syndrome in children with rheumatic disorders.
Moradinejad MH; Ziaee V
Minerva Pediatr; 2011 Dec; 63(6):459-66. PubMed ID: 22075800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
